Dr Kathryn Peall
Clinical Senior Lecturer, Neurosciences & Mental Health Research Institute
- Email:
- peallkj@cardiff.ac.uk
- Telephone:
- +44 (0)29 2068 8338
- Location:
- 3.42, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ
- Welsh speaking
- Available for postgraduate supervision
We are interested in the aetiology and pathophysiological mechanisms that underpin movement disorders, particularly childhood- and adult-onset Dystonia. We are using a combination of epidemiology, imaging, invertebrate and cellular models to gain insight into these disorders, why they occur and the pathways that are likely disrupted. We hope that a more detailed understanding of these mechanisms will help in the development of future novel therapies.
My work is support by the Medical Research Council (Clinician-Scientist Fellowship), the Dystonia Medical Research Foundation, The Dystonia Society and the Life Sciences Research Network Wales.
2018
- Fung, W. and Peall, K. J. 2018. Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson's disease?. Journal of Neurology 265(10), pp. 2463-2465. (10.1007/s00415-018-9046-x)
- Eggink, H.et al. 2018. Motor and non-motor determinants of health-related quality of life in young dystonia patients. Parkinsonism & Related Disorders (10.1016/j.parkreldis.2018.08.008)
- Zutt, R.et al. 2018. Electrophysiologic testing aids diagnosis and subtyping of myoclonus. Neurology 90(8), pp. e647-e657. (10.1212/WNL.0000000000004996)
2017
- Peall, K.et al. 2017. Low CSF 5-HIAA in myoclonus dystonia. Movement Disorders 32(11), pp. 1647-1649. (10.1002/mds.27117)
- Peall, K. J.et al. 2017. A review of psychiatric co-morbidity described in genetic and immune mediated movement disorders. Neuroscience & Biobehavioral Reviews 80, pp. 23-35. (10.1016/j.neubiorev.2017.05.014)
- van de Zande, N. A.et al. 2017. Clinical characterization of dystonia in adult patients with Huntington's disease. European Journal of Neurology 24(9), pp. 1140-1147. (10.1111/ene.13349)
- van Egmond, M. E.et al. 2017. A post hoc study on gene panel analysis for the diagnosis of dystonia. Movement Disorders -New York- 32(4), pp. 569-575. (10.1002/mds.26937)
- Robertson, N. and Peall, K. J. 2017. Dystonia: opportunities to gain insights into underlying pathophysiological mechanisms. Journal of Neurology 264(3), pp. 616-618. (10.1007/s00415-017-8411-5)
2016
- Meyer, E.et al. 2016. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia. Nature Genetics 49(2), pp. 223-237. (10.1038/ng.3740)
- Peall, K. J. and Robertson, N. 2016. Idiopathic rapid eye movement sleep behaviour disorder: a potential gateway to the development of disease-modifying treatments in neurodegenerative disorders. Journal of Neurology 263(8), pp. 1678-1680. (10.1007/s00415-016-8235-8)
- Massey, T., Pickersgill, T. T. and Peall, K. J. 2016. Nitrous oxide misuse and vitamin B12 deficiency. BMJ Case Reports, article number: 215728. (10.1136/bcr-2016-215728)
- Zutt, R.et al. 2016. Distribution and coexistence of myoclonus and dystonia as clinical predictors of SGCE mutation status: a pilot study. Frontiers in Neurology 7, article number: 72. (10.3389/fneur.2016.00072)
2015
- Peall, K. J.et al. 2015. Psychiatric disorders, myoclonus dystonia andSGCE: an international study. Annals of Clinical and Translational Neurology 3(1), pp. 4-11. (10.1002/acn3.263)
- Peall, K. J.et al. 2015. Non-motor symptoms in genetically defined dystonia: homogenous groups require systematic assessment. Parkinsonism & Related Disorders 21(9), pp. 1031-1040. (10.1016/j.parkreldis.2015.07.003)
- Peall, K. J. and Robertson, N. 2015. Biomarkers in Alzheimer's Disease: understanding disease trajectory and therapeutic targets. Journal of Neurology 262(9), pp. 2195-2197. (10.1007/s00415-015-7881-6)
- Peall, K. and Kurian, M. 2015. Benign hereditary chorea: an update. Tremor and Other Hyperkinet Movements 2015, article number: 3. (10.7916/D8RJ4HM5)
- Mencacci, N.et al. 2015. A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystoniaa. American Journal of Human Genetics 96(6), pp. 938-947. (10.1016/j.ajhg.2015.04.008)
2014
- Peall, K. J.et al. 2014. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. Journal of Neurology 261(12), pp. 2296-2304. (10.1007/s00415-014-7488-3)
- Peall, K. 2014. Rare inborn errors of metabolism with movement disorders: a case study to evaluate the impact upon quality of life and adaptive functioning. Orphanet Journal of Rare Diseases 9, article number: 177. (10.1186/s13023-014-0177-6)
- Peall, K. J. and Robertson, N. 2014. Narcolepsy: environment, genes and treatment. Journal of Neurology 261(8), pp. 1644-1646. (10.1007/s00415-014-7435-3)
- Peall, K. J.et al. 2014. SGCZ mutations are unlikely to be associated with myoclonus dystonia. Neuroscience 272, pp. 88-91. (10.1016/j.neuroscience.2014.04.034)
- Peall, K. J.et al. 2014. Benign hereditary chorea related toNKX2.1: expansion of the genotypic and phenotypic spectrum. Developmental Medicine & Child Neurology 56(7), pp. 642-8. (10.1111/dmcn.12323)
2013
- Peall, K. J.et al. 2013. SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain 136(1), pp. 294-303. (10.1093/brain/aws308)
- Peall, K. J. and Robertson, N. 2013. Parkinsonism, dementia and glucocerebrosidase mutations. Journal of Neurology 260(5), pp. 1441-1444. (10.1007/s00415-013-6923-1)
2012
- Peall, K. J.et al. 2012. Myoclonus dystonia syndrome: SGCE mutations and psychiatric disease [Abstract]. Journal of Neurology 259, pp. S30-S30.
- Peall, K. J. 2012. Clinical and genetic investigation of the epsilon-sarcoglycan complex in neurologic and psychiatric disease. PhD Thesis, Cardiff University.
2011
- Peall, K. J.et al. 2011. Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic review. Movement Disorders 26(10), pp. 1939-1942. (10.1002/mds.23791)
I am interested in supervising PhD students, interested in studying dystonia, in the areas of:
- Clinical phenotyping
- Genetics of complex disease
- Invertebrate and in vitro models